|
1
|
Azad MB, Chen Y and Gibson SB: Regulation
of autophagy by reactive oxygen species (ROS): implications for
cancer progression and treatment. Antioxid Redox Signal.
11:777–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Storz P: Reactive oxygen species in tumor
progression. Front Biosci. 10:1881–1896. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brigelius-Flohé R and Kipp A: Glutathione
peroxidases in different stages of carcinogenesis. Biochim Biophys
Acta. 1790:1555–1568. 2009.PubMed/NCBI
|
|
5
|
Wiseman H and Halliwell B: Damage to DNA
by reactive oxygen and nitrogen species: role in inflammatory
disease and progression to cancer. Biochem J. 313:17–29.
1996.PubMed/NCBI
|
|
6
|
Leto TL and Geiszt M: Role of Nox family
NADPH oxidases in host defense. Antioxid Redox Signal. 8:1549–1561.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cullen JJ, Mitros FA and Oberley LW:
Expression of antioxidant enzymes in diseases of the human
pancreas: another link between chronic pancreatitis and pancreatic
cancer. Pancreas. 26:23–27. 2003. View Article : Google Scholar
|
|
8
|
Ono R, Kobayashi S, Wagatsuma H, et al: A
retrotransposon-derived gene, PEG10, is a novel imprinted gene
located on human chromosome 7q21. Genomics. 73:232–237. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okabe H, Satoh S, Furukawa Y, et al:
Involvement of PEG10 in human hepatocellular carcinogenesis through
interaction with SIAH1. Cancer Res. 63:3043–3048. 2003.PubMed/NCBI
|
|
10
|
Kainz B, Shehata M, Bilban M, et al:
Overexpression of the paternally expressed gene 10 (PEG10) from the
imprinted locus on chromosome 7q21 in high-risk B-cell chronic
lymphocytic leukemia. Int J Cancer. 121:1984–1993. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsuji K, Yasui K, Gen Y, et al: PEG10 is a
probable target for the amplification at 7q21 detected in
hepatocellular carcinoma. Cancer Genet Cytogenet. 198:118–125.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chunsong H, Yuling H, Li W, et al: CXC
chemokine ligand 13 and CC chemokine ligand 19 cooperatively render
resistance to apoptosis in B cell lineage acute and chronic
lymphocytic leukemia CD23+CD5+ B cells. J Immunol. 177:6713–6722.
2006.PubMed/NCBI
|
|
13
|
Li CM, Margolin AA, Salas M, et al: PEG10
is a c-MYC target gene in cancer cells. Cancer Res. 66:665–672.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ip WK, Lai PB, Wong NL, et al:
Identification of PEG10 as a progression related biomarker for
hepatocellular carcinoma. Cancer Lett. 250:284–291. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jie X, Lang C, Jian Q, et al: Androgen
activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Oncogene. 26:5741–5751. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lux A, Beil C, Majety M, et al: Human
retroviral gag- and gag-pol-like proteins interact with the
transforming growth factor-beta receptor activin receptor-like
kinase 1. J Biol Chem. 280:8482–8493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ono R, Nakamura K, Inoue K, et al:
Deletion of Peg10, an imprinted gene acquired from a
retrotransposon, causes early embryonic lethality. Nat Genet.
38:101–106. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li L and Cohen SN: Tsg101: a novel tumor
susceptibility gene isolated by controlled homozygous functional
knockout of allelic loci in mammalian cells. Cell. 85:319–329.
1996. View Article : Google Scholar
|
|
19
|
Young TW, Rosen DG, Mei FC, et al:
Up-regulation of tumor susceptibility gene 101 conveys poor
prognosis through suppression of p21 expression in ovarian cancer.
Clin Cancer Res. 13:3848–3854. 2007. View Article : Google Scholar
|
|
20
|
Bashirova AA, Bleiber G, Qi Y, et al:
Consistent effects of TSG101 genetic variability on multiple
outcomes of exposure to human immunodeficiency virus type 1. J
Virol. 80:6757–6763. 2006. View Article : Google Scholar
|
|
21
|
Liu RT, Huang CC, You HL, et al:
Overexpression of tumor susceptibility gene TSG101 in human
papillary thyroid carcinomas. Oncogene. 21:4830–4837. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koon N, Schneider-Stock R, Sarlomo-Rikala
M, et al: Molecular targets for tumour progression in
gastrointestinal stromal tumours. Gut. 53:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma XR, Edmund Sim UH, Pauline B, et al:
Overexpression of WNT2 and TSG101 genes in colorectal carcinoma.
Trop Biomed. 25:46–57. 2008.PubMed/NCBI
|
|
24
|
Zhu G, Gilchrist R, Borley N, et al:
Reduction of TSG101 protein has a negative impact on tumor cell
growth. Int J Cancer. 109:541–547. 2004. View Article : Google Scholar
|
|
25
|
Li L, Liao J, Ruland J, et al: A
TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53
feedback control. Proc Natl Acad Sci USA. 98:1619–1624. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hawkins WG, DeMatteo RP, Jarnagin WR,
Ben-Porat L, Blumgart LH and Fong Y: Jaundice predicts advanced
disease and early mortality in patients with gallbladder cancer.
Ann Surg Oncol. 11:310–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roa JC, Tapia O, Cakir A, Basturk O,
Dursun N, Akdemir D, Saka B, Losada H, Bagci P and Adsay NV:
Squamous cell and adenosquamous carcinomas of the gallbladder:
clinicopathological analysis of 34 cases identified in 606
carcinomas. Mod Pathol. 24:1069–1078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kondo M, Dono K, Sakon M, et al:
Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology.
49:1230–1234. 2002.PubMed/NCBI
|
|
29
|
Muzio G, Maggiora M, Paiuzzi E, Oraldi M
and Canuto RA: Aldehyde dehydrogenases and cell proliferation. Free
Radic Biol Med. 52:735–746. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Y, You H, Liu F, et al:
Differentially expressed gene profiles between multidrug resistant
gastric adenocarcinoma cells and their parental cells. Cancer Lett.
185:211–218. 2002. View Article : Google Scholar
|
|
31
|
Shen H, Pan Y, Han Z, et al: Reversal of
multidrug resistance of gastric cancer cells by downregulation of
TSG101 with TSG101siRNA. Cancer Biol Ther. 3:561–565. 2004.
View Article : Google Scholar
|
